Mother-centered mission
We believe every mother deserves access to care teams, tools and systems prepared for the unexpected.
Our missionDeveloping new approaches to postpartum hemorrhage care.
NEMOW is a medical technology company developing an investigational intrauterine vacuum-based device for postpartum hemorrhage associated with uterine atony. We seek to advance maternal-health innovation through engineering, clinical research, and international collaboration.
The NEMOW UTD is investigational; safety and effectiveness require clinical evaluation.
Watch the NEMOW brand and UTD Device introduction.
NEMOW UTD is an investigational device and is not approved or cleared for clinical use unless otherwise authorized by the relevant regulator.
Postpartum hemorrhage is a major cause of maternal illness and death worldwide. Uterine atony, when the uterus does not contract adequately after childbirth, is one of its leading causes. Rapid recognition and evidence-based treatment remain essential.
When medications are not enough, bleeding may require escalation to additional interventions. NEMOW UTD is being developed around intrauterine vacuum technology; clinical studies are needed to evaluate its safety and effectiveness. It is not a replacement for standard care.
We believe every mother deserves access to care teams, tools and systems prepared for the unexpected.
Our missionThe UTD Device concept brings together insertion, evacuation, sealing and suction connection elements in one system.
Explore the componentsWith a USA headquarters and regional support in India, NEMOW brings a global outlook to maternal healthcare innovation.
Connect with NEMOWThat is the ambition behind NEMOW’s work: helping move maternal healthcare forward through responsible, clinically informed innovation.